Swedish medical detection company SciBase Holding has seen its artificial intelligence (AI) powered device for detecting melanomas, dubbed Nevisense, validated as part of a consensus report that found it effective in detecting potential cancers.
Health Professionals
Postsurgical Keytruda Has Little Impact on Quality of Life in Melanoma
Health-related quality of life among patients with stage 3 melanoma was not significantly affected after receiving postsurgical Keytruda or placebo.
GPs alongside oncologists key for melanoma outcomes
Drug therapies for the treatment of melanoma are advancing, and many now play a role for the treatment of earlier stage disease, according to new research.
Immunotherapy Combination Elicit Waves of Response in Advanced Melanoma
A new algorithm has found that combining immune checkpoint inhibitors bolsters immune response among some patients with advanced melanoma.